Israeli Biotech Shines a 'Light' on Investment Opportunities

Biotech investors who only track the US and European stock exchanges to the exclusion of the Tel Aviv listings may be missing out some fast-growing opportunities. In recent years close to 30 Israeli life science companies have started to trade on the Tel Aviv Stock Exchange (TASE). They follow in the giant footsteps of Jerusalem's Teva Pharmaceuticals (TEVA), the largest generics company in the world to trade both on the TASE and NASDAQ.

Back to news